NGN Capital
NGN Capital is a venture capital firm specializing in investments in the US and European healthcare sector.
Business Model:
Revenue: $5.8M
Employees: 2-10
Rankings
Industries / Tags:
Detailed NGN Capital Information
Geographic Data
Address: 369 Lexington Ave
City: New York
State: NY
Zip: 10017
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
6,431,267Website Global Rank
1,372Website Monthly Traffic
Twitter Followers
Description
NGN Capital is a venture capital firm specializing in investments in the US and European healthcare sector. The fund focuses specifically on investments in the healthcare, pharmaceutical, and biotech sectors including drug products, medical devices, diagnostics, and healthcare services.
Contact Phone:
+12129720077
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 10/2005 | OptiScan Biomedical | Venture Round | 36M |
| 5/2008 | ACT Biotech | Series A | 6.6M |
| 7/2010 | Artisan Pharma | Series C | 0 |
| 7/2017 | Exosome Diagnostics | Series C | 0 |
| 8/2005 | Sightline Technologies | Series D | 0 |
| 3/2006 | EKOS Corporation | Series C | 0 |
| 1/2007 | Tigris Pharmaceuticals | Series B | 16M |
| 3/2010 | Valtech Cardio | Series B | 17.8M |
| 10/2006 | Santhera Pharmaceuticals | Series C | 0 |
| 11/2005 | Javelin Pharmaceuticals | Private Equity Round | 32M |
| 2/2005 | Jerini | Venture Round | 20.2M |
| 1/2016 | Exosome Diagnostics | Series B | 0 |
| 3/2014 | Exosome Diagnostics | Series B | 0 |
| 9/2006 | Artisan Pharma | Series A | 39M |
| 7/2007 | BeneChill | Series B | 3.5M |
| 4/2009 | Aerovance | Venture Round | 38M |
| 11/2013 | Endosense | Series C | 41.2M |
| 12/2004 | Santhera Pharmaceuticals | Series A | 0 |
| 3/2010 | Artisan Pharma | Series B | 22M |
| 7/2012 | Cerapedics | Series C | 0 |
| 4/2009 | Small Bone Innovations | Series D | 0 |
| 11/2012 | Endosense | Series C | 40.3M |
| 5/2010 | Noxxon Pharma | Series D | 40.7M |
| 9/2015 | Exosome Diagnostics | Series B | 0 |
| 2/2005 | EKOS Corporation | Series B | 0 |
| 9/2009 | BeneChill | Series C | 13.5M |
| 3/2007 | Aerovance | Series C | 60M |
| 4/2009 | Cerapedics | Series B | 15M |
| 12/2010 | Small Bone Innovations | Series F | 0 |
| 1/2008 | Small Bone Innovations | Series C | 0 |
| 12/2005 | Small Bone Innovations | Series B | 0 |
| 3/2007 | Nitec Pharma AG | Series B | 26M |
| 8/2004 | Aerovance | Series B | 32M |
| 5/2010 | Exosome Diagnostics | Series A | 20M |
| 12/2005 | Santhera Pharmaceuticals | Series B | 0 |
| 10/2008 | Micromet | Post-IPO Equity | 0 |
| 1/2014 | PIN Pharma | Series A | 6.8M |
| 1/2009 | Vivaldi Biosciences | Series A | 23M |
| 7/2017 | Exosome Diagnostics | Series C | 0 |
| 1/2016 | Exosome Diagnostics | Series B | 0 |
| 9/2015 | Exosome Diagnostics | Series B | 0 |
| 3/2014 | Exosome Diagnostics | Series B | 0 |
| 1/2014 | PIN Pharma | Series A | 0 |
| 11/2013 | Endosense | Series C | 0 |
| 11/2012 | Endosense | Series C | 0 |
| 7/2012 | Cerapedics | Series C | 0 |
| 12/2010 | Small Bone Innovations | Series F | 0 |
| 7/2010 | Artisan Pharma | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
